Article Text
Abstract
Objective The aim of this study was to evaluate the relationship between receipt of the substitutable-for-fee vaccines (SFV) and completion of the expanded programme on immunisation (EPI).
Design and settings A cross-sectional study was conducted in Fujian province, China.
Participants Children who were born from 1 September 2009 to 31 August 2011, and who had been residing in the township for at least 3 months, were randomly recruited from 34 townships.
Main outcomes measures Outcomes were completion rate of the EPI and coverage rate of the SFV.
Results The study included 1428 children, of whom 1350 (94.5%) finished the EPI and 282 (19.7%) received at least one dose of the SFV. Administration of the SFV was associated with an increased likelihood of completing the EPI (OR=3.2, 95% CI 1.3 to 7.6 in the total sample and OR=4.0, 95% CI 1.7 to 9.6 in the subsample of children in regions with the SFV accessibility). The impact of the SFV administration on completion of the EPI was larger among children whose parents have junior school education or less (97.8% and 97.9% vs 92.5% and 91.9%, both p<0.001) and among those with a timely hepatitis B vaccine first dose (98.5% vs 94.0%, p<0.001).
Conclusions Receipt of SFV is associated with increased likelihood of completion of the EPI in Fujian, China.
- expanded program on immunization
- for-fee vaccines
- cross-sectional study
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Statistics from Altmetric.com
Footnotes
Contributors JNW, YZ and DJL had the initial idea for the study and designed the survey. JNW, MRD and HLP collected and analysed the data for this study. JNW wrote the first draft of the manuscript. All authors critically revised the manuscript and approved the final version.
Competing interests None declared.
Patient consent Obtained.
Ethics approval Chinese Center for Disease Control and Prevention.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement No additional data are available.